HEADER OXIDOREDUCTASE 18-JUL-06 2HQ7 TITLE CRYSTAL STRUCTURE OF PROTEIN RELATED TO GENERAL STRESS PROTEIN TITLE 2 26(GS26) OF B.SUBTILIS (PYRIDOXINEPHOSPHATE OXIDASE FAMILY) TITLE 3 (NP_350077.1) FROM CLOSTRIDIUM ACETOBUTYLICUM AT 2.00 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN, RELATED TO GENERAL STRESS PROTEIN 26(GS26) OF COMPND 3 B.SUBTILIS; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: PYRIDOXINEPHOSPHATE OXIDASE FAMILY; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CLOSTRIDIUM ACETOBUTYLICUM; SOURCE 3 ORGANISM_TAXID: 1488; SOURCE 4 GENE: NP_350077.1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS NP_350077.1, PROTEIN RELATED TO GENERAL STRESS PROTEIN 26(GS26) OF KEYWDS 2 B.SUBTILIS (PYRIDOXINEPHOSPHATE OXIDASE FAMILY), STRUCTURAL KEYWDS 3 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 4 STRUCTURE INITIATIVE, PSI, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 5 25-JAN-23 2HQ7 1 REMARK SEQADV LINK REVDAT 4 18-OCT-17 2HQ7 1 REMARK REVDAT 3 13-JUL-11 2HQ7 1 VERSN REVDAT 2 24-FEB-09 2HQ7 1 VERSN REVDAT 1 15-AUG-06 2HQ7 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PROTEIN RELATED TO GENERAL STRESS JRNL TITL 2 PROTEIN 26(GS26) OF B.SUBTILIS (PYRIDOXINEPHOSPHATE OXIDASE JRNL TITL 3 FAMILY) (NP_350077.1) FROM CLOSTRIDIUM ACETOBUTYLICUM AT JRNL TITL 4 2.00 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 19244 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 985 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1326 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.21 REMARK 3 BIN R VALUE (WORKING SET) : 0.2640 REMARK 3 BIN FREE R VALUE SET COUNT : 66 REMARK 3 BIN FREE R VALUE : 0.2810 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2274 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 18 REMARK 3 SOLVENT ATOMS : 141 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 33.35 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.97000 REMARK 3 B22 (A**2) : 3.14000 REMARK 3 B33 (A**2) : -1.57000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.50000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.209 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.180 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.145 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.679 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.923 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2349 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1589 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3167 ; 1.410 ; 1.953 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3879 ; 0.832 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 283 ; 6.313 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 106 ;40.026 ;24.717 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 423 ;15.859 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;19.288 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 347 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2562 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 475 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 435 ; 0.188 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1575 ; 0.194 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1124 ; 0.188 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1327 ; 0.091 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 136 ; 0.180 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 17 ; 0.175 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 32 ; 0.174 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 15 ; 0.167 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1449 ; 2.616 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 577 ; 0.608 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2268 ; 3.575 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1064 ; 6.240 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 898 ; 7.717 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 2 A 142 REMARK 3 ORIGIN FOR THE GROUP (A): -12.6100 2.7640 32.2770 REMARK 3 T TENSOR REMARK 3 T11: -0.0072 T22: -0.0402 REMARK 3 T33: -0.0189 T12: -0.0104 REMARK 3 T13: -0.0049 T23: 0.0341 REMARK 3 L TENSOR REMARK 3 L11: 0.9959 L22: 0.7537 REMARK 3 L33: 0.7719 L12: -0.7125 REMARK 3 L13: -0.4292 L23: 0.0377 REMARK 3 S TENSOR REMARK 3 S11: -0.0276 S12: -0.0767 S13: 0.0550 REMARK 3 S21: 0.0229 S22: -0.0229 S23: -0.0565 REMARK 3 S31: -0.0319 S32: 0.0469 S33: 0.0505 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 2 B 143 REMARK 3 ORIGIN FOR THE GROUP (A): -7.9660 -5.4290 12.8880 REMARK 3 T TENSOR REMARK 3 T11: 0.0183 T22: -0.1205 REMARK 3 T33: 0.0028 T12: 0.0066 REMARK 3 T13: -0.0180 T23: 0.0162 REMARK 3 L TENSOR REMARK 3 L11: 1.6270 L22: 0.4115 REMARK 3 L33: 1.4238 L12: -0.1091 REMARK 3 L13: -0.3088 L23: 0.5681 REMARK 3 S TENSOR REMARK 3 S11: -0.0251 S12: -0.0562 S13: 0.0705 REMARK 3 S21: -0.1281 S22: -0.0359 S23: 0.0668 REMARK 3 S31: -0.0128 S32: 0.0418 S33: 0.0609 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. REMARK 3 3. RESIDUES A1, A143-145, B1, AND B144-145 ARE DISORDERED AND NOT REMARK 3 INCLUDED IN THE MODEL. REMARK 3 4. EDO AND CL FROM THE CRYSTALLIZATION/CRYO SOLUTION ARE MODELED. REMARK 3 5. ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. REMARK 4 REMARK 4 2HQ7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-JUL-06. REMARK 100 THE DEPOSITION ID IS D_1000038631. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97934, 0.91837 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : FLAT COLLIMATING MIRROR, TOROID REMARK 200 FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19245 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 29.235 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.39200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M CA(OAC)2, 20.0% PEG-3000, 0.1M REMARK 280 TRIS PH 7.0, VAPOR DIFFUSION,SITTING DROP,NANODROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 42.92500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 18.39500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 42.92500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 18.39500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13870 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -88.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 TYR A 143 REMARK 465 ASN A 144 REMARK 465 TYR A 145 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 465 ASN B 144 REMARK 465 TYR B 145 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 5 CG CD CE NZ REMARK 470 LEU A 7 CG CD1 CD2 REMARK 470 LYS A 18 CG CD CE NZ REMARK 470 GLU A 27 CD OE1 OE2 REMARK 470 ARG A 56 CZ NH1 NH2 REMARK 470 LYS A 62 CD CE NZ REMARK 470 LYS A 63 CE NZ REMARK 470 LYS B 5 CE NZ REMARK 470 GLU B 9 CD OE1 OE2 REMARK 470 GLU B 12 CG CD OE1 OE2 REMARK 470 GLU B 27 CD OE1 OE2 REMARK 470 ARG B 56 NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG B 130 143.80 -175.40 REMARK 500 ILE B 142 3.10 -67.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL B 72 ASP B 73 149.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 146 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 146 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 147 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 148 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 149 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 147 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 366858 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV REMARK 999 PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE REMARK 999 TARGET SEQUENCE. DBREF 2HQ7 A 1 145 UNP Q97DI6 Q97DI6_CLOAB 1 145 DBREF 2HQ7 B 1 145 UNP Q97DI6 Q97DI6_CLOAB 1 145 SEQADV 2HQ7 GLY A 0 UNP Q97DI6 EXPRESSION TAG SEQADV 2HQ7 MSE A 1 UNP Q97DI6 MET 1 MODIFIED RESIDUE SEQADV 2HQ7 MSE A 21 UNP Q97DI6 MET 21 MODIFIED RESIDUE SEQADV 2HQ7 MSE A 36 UNP Q97DI6 MET 36 MODIFIED RESIDUE SEQADV 2HQ7 MSE A 37 UNP Q97DI6 MET 37 MODIFIED RESIDUE SEQADV 2HQ7 MSE A 57 UNP Q97DI6 MET 57 MODIFIED RESIDUE SEQADV 2HQ7 MSE A 81 UNP Q97DI6 MET 81 MODIFIED RESIDUE SEQADV 2HQ7 MSE A 97 UNP Q97DI6 MET 97 MODIFIED RESIDUE SEQADV 2HQ7 GLY B 0 UNP Q97DI6 EXPRESSION TAG SEQADV 2HQ7 MSE B 1 UNP Q97DI6 MET 1 MODIFIED RESIDUE SEQADV 2HQ7 MSE B 21 UNP Q97DI6 MET 21 MODIFIED RESIDUE SEQADV 2HQ7 MSE B 36 UNP Q97DI6 MET 36 MODIFIED RESIDUE SEQADV 2HQ7 MSE B 37 UNP Q97DI6 MET 37 MODIFIED RESIDUE SEQADV 2HQ7 MSE B 57 UNP Q97DI6 MET 57 MODIFIED RESIDUE SEQADV 2HQ7 MSE B 81 UNP Q97DI6 MET 81 MODIFIED RESIDUE SEQADV 2HQ7 MSE B 97 UNP Q97DI6 MET 97 MODIFIED RESIDUE SEQRES 1 A 146 GLY MSE ILE ASP GLU LYS PHE LEU ILE GLU SER ASN GLU SEQRES 2 A 146 LEU VAL GLU SER SER LYS ILE VAL MSE VAL GLY THR ASN SEQRES 3 A 146 GLY GLU ASN GLY TYR PRO ASN ILE LYS ALA MSE MSE ARG SEQRES 4 A 146 LEU LYS HIS ASP GLY LEU LYS LYS PHE TRP LEU SER THR SEQRES 5 A 146 ASN THR SER THR ARG MSE VAL GLU ARG LEU LYS LYS ASN SEQRES 6 A 146 ASN LYS ILE CYS LEU TYR PHE VAL ASP ASP ASN LYS PHE SEQRES 7 A 146 ALA GLY LEU MSE LEU VAL GLY THR ILE GLU ILE LEU HIS SEQRES 8 A 146 ASP ARG ALA SER LYS GLU MSE LEU TRP THR ASP GLY CYS SEQRES 9 A 146 GLU ILE TYR TYR PRO LEU GLY ILE ASP ASP PRO ASP TYR SEQRES 10 A 146 THR ALA LEU CYS PHE THR ALA GLU TRP GLY ASN TYR TYR SEQRES 11 A 146 ARG HIS LEU LYS ASN ILE THR PHE LYS ILE ASP GLU ILE SEQRES 12 A 146 TYR ASN TYR SEQRES 1 B 146 GLY MSE ILE ASP GLU LYS PHE LEU ILE GLU SER ASN GLU SEQRES 2 B 146 LEU VAL GLU SER SER LYS ILE VAL MSE VAL GLY THR ASN SEQRES 3 B 146 GLY GLU ASN GLY TYR PRO ASN ILE LYS ALA MSE MSE ARG SEQRES 4 B 146 LEU LYS HIS ASP GLY LEU LYS LYS PHE TRP LEU SER THR SEQRES 5 B 146 ASN THR SER THR ARG MSE VAL GLU ARG LEU LYS LYS ASN SEQRES 6 B 146 ASN LYS ILE CYS LEU TYR PHE VAL ASP ASP ASN LYS PHE SEQRES 7 B 146 ALA GLY LEU MSE LEU VAL GLY THR ILE GLU ILE LEU HIS SEQRES 8 B 146 ASP ARG ALA SER LYS GLU MSE LEU TRP THR ASP GLY CYS SEQRES 9 B 146 GLU ILE TYR TYR PRO LEU GLY ILE ASP ASP PRO ASP TYR SEQRES 10 B 146 THR ALA LEU CYS PHE THR ALA GLU TRP GLY ASN TYR TYR SEQRES 11 B 146 ARG HIS LEU LYS ASN ILE THR PHE LYS ILE ASP GLU ILE SEQRES 12 B 146 TYR ASN TYR MODRES 2HQ7 MSE A 21 MET SELENOMETHIONINE MODRES 2HQ7 MSE A 36 MET SELENOMETHIONINE MODRES 2HQ7 MSE A 37 MET SELENOMETHIONINE MODRES 2HQ7 MSE A 57 MET SELENOMETHIONINE MODRES 2HQ7 MSE A 81 MET SELENOMETHIONINE MODRES 2HQ7 MSE A 97 MET SELENOMETHIONINE MODRES 2HQ7 MSE B 21 MET SELENOMETHIONINE MODRES 2HQ7 MSE B 36 MET SELENOMETHIONINE MODRES 2HQ7 MSE B 37 MET SELENOMETHIONINE MODRES 2HQ7 MSE B 57 MET SELENOMETHIONINE MODRES 2HQ7 MSE B 81 MET SELENOMETHIONINE MODRES 2HQ7 MSE B 97 MET SELENOMETHIONINE HET MSE A 21 8 HET MSE A 36 8 HET MSE A 37 8 HET MSE A 57 8 HET MSE A 81 8 HET MSE A 97 8 HET MSE B 21 8 HET MSE B 36 8 HET MSE B 37 8 HET MSE B 57 8 HET MSE B 81 8 HET MSE B 97 8 HET CL A 146 1 HET EDO A 147 4 HET EDO A 148 4 HET EDO A 149 4 HET CL B 146 1 HET EDO B 147 4 HETNAM MSE SELENOMETHIONINE HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 3 CL 2(CL 1-) FORMUL 4 EDO 4(C2 H6 O2) FORMUL 9 HOH *141(H2 O) HELIX 1 1 GLU A 4 SER A 17 1 14 HELIX 2 2 GLU A 27 GLY A 29 5 3 HELIX 3 3 SER A 54 ASN A 64 1 11 HELIX 4 4 ASP A 91 TRP A 99 1 9 HELIX 5 5 GLY A 102 TYR A 107 1 6 HELIX 6 6 LEU A 109 ASP A 113 5 5 HELIX 7 7 ASP A 140 ILE A 142 5 3 HELIX 8 8 GLU B 4 SER B 16 1 13 HELIX 9 9 GLU B 27 GLY B 29 5 3 HELIX 10 10 SER B 54 ASN B 64 1 11 HELIX 11 11 ASP B 91 TRP B 99 1 9 HELIX 12 12 LEU B 109 ASP B 113 5 5 SHEET 1 A 8 LYS A 133 LYS A 138 0 SHEET 2 A 8 TYR A 116 ARG A 130 -1 N GLY A 126 O PHE A 137 SHEET 3 A 8 ALA A 78 LEU A 89 -1 N VAL A 83 O GLU A 124 SHEET 4 A 8 LYS A 66 VAL A 72 -1 N PHE A 71 O LEU A 80 SHEET 5 A 8 ILE A 19 ASN A 25 -1 N GLY A 23 O CYS A 68 SHEET 6 A 8 PRO A 31 ASP A 42 -1 O MSE A 36 N VAL A 20 SHEET 7 A 8 LYS A 46 ASN A 52 -1 O TRP A 48 N LYS A 40 SHEET 8 A 8 TYR A 116 ARG A 130 -1 O PHE A 121 N PHE A 47 SHEET 1 B 8 LYS B 133 LYS B 138 0 SHEET 2 B 8 TYR B 116 ARG B 130 -1 N GLY B 126 O PHE B 137 SHEET 3 B 8 ALA B 78 LEU B 89 -1 N VAL B 83 O GLU B 124 SHEET 4 B 8 LYS B 66 ASP B 73 -1 N LEU B 69 O LEU B 82 SHEET 5 B 8 ILE B 19 ASN B 25 -1 N GLY B 23 O CYS B 68 SHEET 6 B 8 PRO B 31 ASP B 42 -1 O LYS B 34 N VAL B 22 SHEET 7 B 8 LYS B 46 ASN B 52 -1 O TRP B 48 N LYS B 40 SHEET 8 B 8 TYR B 116 ARG B 130 -1 O PHE B 121 N PHE B 47 LINK C VAL A 20 N MSE A 21 1555 1555 1.34 LINK C MSE A 21 N VAL A 22 1555 1555 1.32 LINK C ALA A 35 N MSE A 36 1555 1555 1.33 LINK C MSE A 36 N MSE A 37 1555 1555 1.32 LINK C MSE A 37 N ARG A 38 1555 1555 1.32 LINK C ARG A 56 N MSE A 57 1555 1555 1.32 LINK C MSE A 57 N VAL A 58 1555 1555 1.33 LINK C LEU A 80 N MSE A 81 1555 1555 1.32 LINK C MSE A 81 N LEU A 82 1555 1555 1.32 LINK C GLU A 96 N MSE A 97 1555 1555 1.33 LINK C MSE A 97 N LEU A 98 1555 1555 1.33 LINK C VAL B 20 N MSE B 21 1555 1555 1.33 LINK C MSE B 21 N VAL B 22 1555 1555 1.32 LINK C ALA B 35 N MSE B 36 1555 1555 1.33 LINK C MSE B 36 N MSE B 37 1555 1555 1.32 LINK C MSE B 37 N ARG B 38 1555 1555 1.32 LINK C ARG B 56 N MSE B 57 1555 1555 1.33 LINK C MSE B 57 N VAL B 58 1555 1555 1.33 LINK C LEU B 80 N MSE B 81 1555 1555 1.33 LINK C MSE B 81 N LEU B 82 1555 1555 1.33 LINK C GLU B 96 N MSE B 97 1555 1555 1.33 LINK C MSE B 97 N LEU B 98 1555 1555 1.32 SITE 1 AC1 1 ASP B 91 SITE 1 AC2 4 LYS A 63 ASN A 65 ASP A 101 HOH A 221 SITE 1 AC3 9 THR A 51 ASN A 52 THR A 53 SER A 54 SITE 2 AC3 9 MSE A 57 VAL A 58 THR A 117 HOH A 201 SITE 3 AC3 9 HOH A 205 SITE 1 AC4 6 LEU A 39 LYS A 40 MSE A 97 LEU A 98 SITE 2 AC4 6 TRP A 99 THR A 100 SITE 1 AC5 4 ASN A 52 PHE B 77 TYR B 129 LEU B 132 SITE 1 AC6 5 GLU B 87 ILE B 88 LEU B 89 HIS B 90 SITE 2 AC6 5 ASP B 91 CRYST1 85.850 36.790 97.970 90.00 113.75 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011650 0.000000 0.005130 0.00000 SCALE2 0.000000 0.027180 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011150 0.00000